The effect of ınflıxımab and octreotıde on cytokıne levels experımental prolıferatıve vıtreoretınopathy.

Conclusions: Intravitreal infliximab can inhibit the development of PVR and reduce levels of cytokine, which plays an essential role in the pathogenesis of PVR. The results of our study suggest that it may be possible to identify the ideal adjuvant pharmacological drugs that are effective in preventing PVR. PMID: 31809602 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31809602?dopt=Abstract

Source: Cutaneous and Ocular Toxicology - December 5, 2019 Category: Toxicology Authors: Savur F, Aydemir O, İlhan N Tags: Cutan Ocul Toxicol Source Type: research